Smoking cessation in cancer care
Build the case for tobacco dependence treatment at the point of cancer diagnosis.
View tool →Free tools for clinicians and cancer managers: business case toolkits that turn peer-reviewed health economic evidence into local numbers, and procedural passports that measure the quality of the procedures behind a diagnosis.
Green et al., Lancet Regional Health – Europe, 2026
Build the case for tobacco dependence treatment at the point of cancer diagnosis.
View tool →Start treatment at the screening visit with an embedded team, not a referral.
View tool →Logbooks and self-calculating dashboards aligned to BTS standards.
View tool →Four ultrasound levels and eight pleural procedures, with CiP pathways.
View tool →Built by clinicians, for clinicians and cancer managers. Each tool is free to download, fully referenced, and clear about its funding and limitations. These are decision-support tools, not a substitute for local costing or formal appraisal. Read the full disclaimer.
Business case toolkits come with an Excel calculator, a Word business case template and a briefing. Procedural passports are Excel workbooks for logging procedures and tracking quality indicators. More tools will be added as their underlying research is published.
Build the case for offering tobacco dependence treatment at the point of cancer diagnosis, within the cancer pathway.
Evidence: Green et al., Lancet Regional Health – Europe 2026
View tool →Build the case for starting treatment at the screening visit with an embedded team, rather than referring people on.
Evidence: Evison et al., Thorax 2026; Fewster et al., J Med Econ 2026
View tool →Logbooks and performance dashboards for basic diagnostic bronchoscopy, peripheral bronchoscopy and EBUS, with quality indicators and reflective practice.
Aligned to BTS standards for diagnostic flexible bronchoscopy and EBUS-TBNA
View tool →Logbooks and dashboards for four levels of thoracic ultrasound and eight pleural procedures, with capability-in-practice pathways.
Aligned to BTS Training Standards for Thoracic Ultrasound (2020) and Pleural Procedures (2025)
View tool →Costs, savings and outcomes of prehabilitation across the lung cancer pathway.
The health economics of rapid on-site evaluation in lung cancer diagnostics.
Service model and evaluation of a one-stop diagnostic clinic.
Tools / Smoking cessation in cancer care
Estimate the investment, health gain and NHS budget impact of offering tobacco dependence treatment at the point of cancer diagnosis, for the people diagnosed in your organisation each year.
Continuing to smoke after a cancer diagnosis worsens survival, increases progression and raises treatment complications. Stopping after diagnosis reduces the risk of progression and death. Yet in England, support usually depends on referral out to a community stop smoking service, and in the published model only about 17% of people take up support that way.
Stop smoking support offered at diagnosis, as part of cancer care, was cost-effective in all four populations modelled over a lifetime horizon. Cost per QALY gained against the £20,000 NICE threshold:
The result held whenever uptake was above about 12–14%, and until delivery costs reached £2,000–£6,600 per person. Over a one-year horizon the intervention was cost-saving in all four populations.
The Excel tool applies the published model results to your own patient numbers, re-running at your expected uptake.
| You enter | You get |
|---|---|
| New diagnoses each year for lung, head and neck, kidney and other cancers | People offered support, uptake and additional long-term quitters |
| % who smoke at diagnosis and % you plan to offer support | Annual investment in the service |
| Expected uptake (base case 74.8%) | Net NHS budget impact at 1, 5, 10 and 15 years and lifetime, plus a five-year cash profile |
| Optional local staffing, medicines and other costs | QALYs, life-years, cost per QALY and net monetary benefit |
| Deprivation profile of the people you will treat | Benefit by IMD quintile and a summary paragraph for your board paper |
Green M, Harper S, Telfer-Thomas E, Agrawal S, Callister MEJ, Lane JL, Warren G, Murray RL, Evison M, Sheikh M, Malcolm R. Economic and health impact of integrating smoking cessation services into NHS cancer care pathways in England: a modelling study. Lancet Reg Health Eur 2026;71:101869. doi:10.1016/j.lanepe.2026.101869. Open access (CC BY IGO).
Tools / Tobacco dependence treatment in lung cancer screening
Turn the national evidence into your own numbers: the costs, health benefits and NHS cost avoidance of starting tobacco dependence treatment at the screening visit, with ongoing support from an embedded team.
Around one in three people attending lung cancer screening smoke. Screening is a powerful teachable moment, but the national service specification funds only very brief advice and onward referral, and fewer than one in five people referred engage with stop smoking support. There is no national funding stream for integrated services, so they depend on local business cases.
Compared with onward referral, an integrated service at the screening visit is cost-saving and improves health. Per person who smokes:
| You enter | You get |
|---|---|
| Annual lung health check or screening attendances, and % who smoke | Additional people starting treatment and quitting at 12 months |
| Current engagement with referral (default 17.4%) and expected uptake (default 74.8%) | Investment and cost per additional quitter |
| Treatment mix, and medicine and vape unit costs | Ten-year budget impact, break-even year, return on investment and net present value |
| Staffing (band, WTE) and non-pay costs | QALYs, cost-effectiveness and pessimistic scenarios |
| Deprivation profile of attendees who smoke | Health gain by IMD quintile, and every figure for the template with field codes F01–F33 |
A built-in validation sheet confirms the tool reproduces the published Thorax results when the published inputs are used.
Worked example with illustrative inputs: 8,000 attendances and 2,640 people who smoke gives about 302 more quitters a year, an annual investment of £387,000, break-even in year 4, and £4.79 of lifetime NHS cost avoided per £1 invested.
Evison M, Naylor R, Malcolm R, et al. Health economic model to evaluate the cost-effectiveness of smoking cessation services integrated within lung cancer screening in the United Kingdom. Thorax 2026. doi:10.1136/thorax-2024-222815
Fewster H, Nuttall P, Evison M, Holmes H, Malcolm R. Reforming the delivery of smoking cessation: a distributional cost-effectiveness analysis of providing smoking cessation as part of targeted lung cancer screening. J Med Econ 2026;29:1180–1194. doi:10.1080/13696998.2026.2655085
Tools / Bronchoscopy Passport
A personal logbook and performance dashboard for bronchoscopists: record each procedure once and see your quality indicators calculate automatically against BTS standards.
Bronchoscopy and EBUS sit at the centre of the lung cancer diagnostic pathway. The quality of each procedure decides whether a patient gets a diagnosis and an accurate stage first time, or needs a repeat test. Most operators keep logbooks for training sign-off, but few can see their own diagnostic yield, sampling completeness or complication rates at a glance.
| Section | What it records and measures |
|---|---|
| Basic diagnostic bronchoscopy | Logbook and dashboard: supervision level, indications, key findings, complications and quality indicators |
| Peripheral bronchoscopy | Logbook and dashboard for peripheral lesion sampling, including radial EBUS and navigation, with diagnostic-yield indicators |
| EBUS | Three linked logbooks (generic, staging, diagnostic) and a combined dashboard, including a prevalence-adjusted benchmark table |
| Reflective practice | Case reflection, critical incident review and peer feedback templates |
| CPD record | Sessions, self-directed learning and conferences, with automatic hours totals |
The logbooks include a hospital number field. Store the workbook in line with your organisation's information governance policy, on an approved and encrypted NHS drive, and never on a personal device.
Tools / Pleural Passport
A personal logbook and performance dashboard for thoracic ultrasound and pleural procedures, built around the British Thoracic Society training standards and capability-in-practice pathways.
Pleural procedures are common, and complications can be serious. Training standards set out what operators should achieve at each level, but tracking your own numbers, success rates and complications across several procedures is hard without a single structured record.
| Section | What it records and measures |
|---|---|
| Thoracic ultrasound (4 logbooks) | Emergency, primary, advanced and expert operator levels: findings, site marking and success, diaphragm assessment |
| Pleural procedures (8 logbooks) | Diagnostic and therapeutic aspiration, Seldinger and blunt-dissection chest drains, indwelling pleural catheter insertion and removal, local anaesthetic thoracoscopy, and ultrasound-guided pleural biopsy |
| Dashboards (12) | Performance metrics and quality indicators that calculate automatically for every logbook |
| CiP pathways | Summary of the BTS capability-in-practice entrustment pathways for each procedure |
| Reflective practice and CPD | Case reflection, critical incident and peer feedback templates; CPD logs with hours totals |
The logbooks include a hospital number field. Store the workbook in line with your organisation's information governance policy, on an approved and encrypted NHS drive, and never on a personal device.
Clinical teams often know what would improve care but lack the time and support to show what it costs, what it returns, and how well it is being delivered. National evidence does not fund local services; local business cases do. And quality cannot be improved without being measured. This site exists to help clinical teams drive service improvement, transformation and innovation, delivering evidence-based care that gives value for the NHS.
The site is curated by Professor Matthew Evison, Consultant Respiratory Physician and Professor of Respiratory Medicine at Manchester University NHS Foundation Trust, where he is Clinical Director for Lung Cancer and Thoracic Surgery. He is a member of the NHS England Clinical Expert Group for Thoracic Oncology and the Royal College of Physicians Tobacco Advisory Group, and is Clinical Lead for Make Smoking History in Greater Manchester.
The site is run in a personal capacity. It is not an official website of any NHS organisation.
The health economic models behind the business case toolkits were built by the York Health Economics Consortium. The research has been supported by Manchester University NHS Foundation Trust and Greater Manchester Cancer Alliance, and shaped by clinical reference groups and reviewers who are named on each tool page.
The tools on this site are decision-support aids for service planning. They produce modelled estimates based on published research and the inputs you enter. They are not a guarantee of costs, savings or outcomes, and they are not a substitute for local costing, finance review or formal appraisal. They do not give clinical advice about individual patients.
You are responsible for checking every input and output before use, and for any decisions made with them. The tools are provided as they are, without warranty, and no liability is accepted for any loss arising from their use.
This site is run by Professor Matthew Evison in a personal capacity. It is not an official website of Manchester University NHS Foundation Trust, Greater Manchester Cancer Alliance, NHS England or any other organisation. Acknowledging an organisation's support does not mean it endorses this site.
Each tool page separates two things. The research is the funded project that produced the peer-reviewed health economic model; its funding is stated exactly as declared in the published papers. The toolkit is the business case calculator, template and briefing built afterwards from the published results. Where industry funding supported the research, it was provided through grants with no funder input into study design, analysis, interpretation, writing or conclusions. No funder has had any input into the business case tools or this site.
All tools on this site are © 2026 Professor Matthew Evison. Each download carries its own terms, which take precedence.
Published papers remain under their publishers' licences, and the research behind each toolkit is credited to its funders and authors on the tool page. Please cite the source paper wherever its results are used.
Each tool shows its version and date. If you find an error, or the evidence changes, the tool will be updated and the version number changed.
This site does not ask for, collect or store any personal data. The Excel tools run entirely on your own computer.
The procedural passports have fields for hospital numbers. Anyone recording patient identifiers is responsible for storing the workbook in line with their organisation's information governance policy, for example on an approved, encrypted NHS drive and never on a personal device.